Juniper Publishers Journal Of Material Science

Abstract Introduction:  This experimental study examined the effect of erythropoietin on a rat model and particularly in an oviductal ischemia reperfusion (IR) protocol. The effects of that molecule were studied pathologically using mean oviductal congestion (OC) lesions. Materials and methods: 40 rats of mean weight 247.7g were used in the study. OC lesions were evaluated at 60 min (groups A and C) and at 120min (groups B and D) of reperfusion. Erythropoietin was administered only in groups C and D. Results: Epo administration significantly decreased the OC scores by 0.3 without lesions [-0.6200848 - 0.0200848] (p= 0.0496). Reperfusion kept non-significantly increased the OC scores by 0.25 without lesions [-0.4759001 - 0.1759001] (P=0.2831). Together, the Epo administration and reperfusion time non significantly decreased the OC scores by 0.1090909 without lesions [-0.3078424 - 0.0896606] (p=0.2735). Conclusion:  Epo administration significantly decreased the OC score...

With recent advances in biotechnology, there has been a plethora of biomaterials in the form of various dental materials and maxillofacial implants, being routinely used for comprehensive oral rehabilitation. Even though these have considerably enhanced the treatment outcomes, but at times the improper application and lack of safety precaution with these have raised many moral and ethical issues. Due to commercial and marketing pressures, technological developments in biomaterials have led to ethical issues being conveniently buried. Lack of stringent regulations and want of strict institutional control results in products that are not truly safe for patients to be marketed and used by unsuspecting clinicians. Clinicians need to be aware of the various bio-safety aspects of the biomaterials that are commonly in use and also ensure that the patients’ rights of informed consent, beneficence, non-malfeasance and autonomy are protected. There is an urgent need for all healthcare spe...

Material science - Juniper publishers Abstract Cancer is one of the leading causes of morbidity and mortality worldwide, more than 600 000 people die annually in the US along. In reality, no matter what kind of cancer, the survival rate is much higher and the expense is much lower for people diagnosed with early stage cancer than with later stage cancer. However, current clinical techniques are difficult to detect cancer in the early stage, due to their small size and the fact that they are hidden very deep. Nano materials provide incredible properties, such as high relative surface area, quantum confinement, etc., which have been largely used for early detection. This mini review gives a simple overview of current progress in the field of nano materials for early detection of cancer. Keywords: Nano materials; Early detection; Cancer; Liquid biopsy; CTCs; Exosome; CtDNA; MiRNA Go to Introduction According to the American Cancer Society, 600,920 cancer deaths are pr...